Securities code: 000710 securities abbreviation: Berry Genomics Co.Ltd(000710) Announcement No.: 2022-003 Berry Genomics Co.Ltd(000710)
Announcement on the reduction of 1% of the company's shares by the controlling shareholders and their persons acting in concert
Mr. Gao Yang, the shareholder holding more than 5% of the shares, and Ms. Hou Ying, the person acting in concert, guarantee that the information provided to the company is true, accurate and complete without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the information disclosure obligor. Berry Genomics Co.Ltd(000710) (hereinafter referred to as "the company") has received the notification letter on the cumulative reduction of shares up to 1% (hereinafter referred to as "the reduction") from Mr. Gao Yang, the controlling shareholder and actual controller of the company, and Ms. Hou Ying, the person acting in concert.
1、 Relevant information of this reduction 1 Basic information
The obligor of information disclosure is highly praised;
Hou Ying (Gao Yang's concerted action)
Address: Building 5, courtyard 4, shengshengyuan Road, Science Park, Changping District, Beijing
Equity change time: June 29, 2021;
December 31, 2021
Stock abbreviation Berry Genomics Co.Ltd(000710) stock code 000710
Change type increase □ decrease persons acting in concert none □
Whether it is the largest shareholder or actual controller yes no □
2. Changes in equity
Type of shares number of shares reduced (10000 shares) reduction proportion (%)
A shares (Gaoyang) 895.00002.5239
A shares (Hou Ying, Gaoyang I) 280.00000.7896
(to the actor)
Total 1175.00003.3135
Centralized trading through stock exchange □
The way of equity change is through block trading in the stock exchange
Others (agreement transfer)
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Gao Yang
Shares held before this change shares held after this change
Nature of shares proportion of shares (10000 shares) to total share capital proportion of shares (10000 shares) to total share capital (%) (%)
Total shares held 4926.057213.89164031.057211.3677
Including: shares with unlimited sales conditions 1231.51433.4729336.51430.9490
Shares with limited sales conditions 3694.542910.41873694.542910.4187
Hou Ying (Gao Yang's concerted action)
Held before this change held after this change held before this change held shares of stock nature held after this change held shares
Proportion of shares (10000 shares) to total share capital (%) of shares (10000 shares) to total share capital (%)
Total shares held 2615.56617.37602335.56616.5864
Including: shares with unlimited sales conditions 653.89151.8440373.89151.0544
Shares with limited sales conditions 1961.67465.53201961.67465.5320
Gao Yang and Hou Ying who acted in concert
Held before this change held after this change held before this change held shares of stock nature held after this change held shares
Proportion of shares (10000 shares) to total share capital (%) of shares (10000 shares) to total share capital (%)
Total shares held 7541.623321.26766366.623317.9541
Including: shares with unlimited sales conditions 1885.40585.3169710.40582.0034
Shares with limited sales conditions 5656.217515.95075656.217515.9507
4. Implementation of commitments, plans, etc
Yes no □
1. Mr. Gao Yang and Ms. Hou Ying, the person acting in concert, subscribed for 49260572 new shares with the equity of Beirui and Kang respectively in the transaction of issuing shares to purchase 100% equity of Beijing Beirui and Kang Biotechnology Co., Ltd. (hereinafter referred to as "Beirui and Kang") and selling major assets (hereinafter referred to as "this major asset restructuring") 26155661 shares (all shares with limited sales conditions). According to the share locking commitment made by Mr. Gao Yang and Ms. Hou Ying, who acted in concert, in this major asset restructuring (for details, see the company's website on April 17, 2017 and August 10, 2017 respectively)（ http://www.cn.info.com..cn. ）Disclosed announcement), whether the above change is a new share, which has been listed and circulated on December 4, 2020 (for details, see the commitment made by the company in 2020 on December 3 on cninfo.com（ http://www.cn.info.com..cn. ）Disclosure announcement). Gao yangnuo, Mr. intention, Mr. plan and Ms. Hou Ying, who acted in concert, all the shares reduced this time come from the above listed and circulating shares. The reduction is consistent with the previously disclosed intentions and commitments.
2. Mr. Gao Yang and Ms. Hou Ying, who acted in concert, are directors and senior managers of the company. In accordance with the company law, the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange and other relevant provisions, Mr. Gao Yang and Ms. Hou Ying, the person acting in concert, are required to abide by the restrictions on share transfer of 25% per year. Mr. Gao Yang and Ms. Hou Ying, the person acting in concert, all the shares reduced this time come from the transferable part. There is no violation of relevant provisions on restrictions on share transfer in this reduction.
Is there any violation of the securities law and the acquisition of Listed Companies in this change
Management measures and other laws yes □ no
Laws, administrative regulations, departmental rules, normative documents and the business rules of the exchange 5 Shares with restricted voting rights
In accordance with article of the securities law
Article 63, yes □ no
Whether there are shares that cannot exercise voting rights 6 Further explanation on the increase of shares held by more than 30% shareholders (not applicable) 7 Documents for future reference 1. Details of shareholding changes of China Securities Depository and Clearing Co., Ltd.
2. Other documents required by SZSE
2、 Other relevant instructions
1. Mr. Gao Yang and Ms. Hou Ying, who acted in concert, strictly abide by the company law, the stock listing rules of Shenzhen Stock Exchange, the guidelines for the standardized operation of companies listed on the main board of Shenzhen Stock Exchange, the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of companies listed on Shenzhen Stock Exchange and other relevant laws, regulations and rules There is no violation of the provisions of the business rules on share transfer. 2. Mr. Gao Yang is the controlling shareholder and actual controller of the company. The reduction did not lead to the change of the company's control and had no significant adverse impact on the company's governance structure and sustainable production and operation.
3. The shares held by Mr. Gao Yang and Ms. Hou Ying, who acted in concert, are still specific shares, and will still comply with the relevant restrictive provisions on share changes such as the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange.
4. There is still uncertainty about whether Mr. Gao Yang and Ms. Hou Ying, who acted in concert, will continue to reduce their holdings in the future. The company will continue to pay attention to its willingness to reduce its holdings and fulfill its obligation of information disclosure in time. Please pay attention to investment risks.
It is hereby announced.
Berry Genomics Co.Ltd(000710) board of directors January 5, 2022
